PBAX
Phoenix Biotech Acquisition Corp.
$5.85
%
Analyst Rating:N/A

Stock Details

CEO

Christopher B. Ehrlich

Sector

Financial Services

Industry

Shell Companies

Full Time Employees

0

Address

2201 Broadway, Oakland, CA, 94612

Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, California.

Income Statement  

Financials

Selected Year

Revenue Estimates

EPS Estimates

Net Income Estimates

Price target for Phoenix Biotech Acquisition Corp.  $5.85

EPS

Revenue

Congress Tracker 

Insider Trading of Key Employees

Financial News: PBAX